share_log

AppYea Chairman Bary Molchadsky Demonstrates Confidence by Converting Debt to Warrants With a Strike Price Set at a 250% Premium to Current Market Price of the Company's Common Stock

AppYea Chairman Bary Molchadsky Demonstrates Confidence by Converting Debt to Warrants With a Strike Price Set at a 250% Premium to Current Market Price of the Company's Common Stock

AppYEA董事長巴里·莫爾查德斯基通過將債務轉換爲認股權證來表現出信心,其行使價定爲公司普通股當前市場價格高出250%
Accesswire ·  05/17 03:30

NEW YORK, NY / ACCESSWIRE / May 16, 2024 / AppYea Inc. (OTCQB:APYP), developer of an innovative wearable monitoring solution to monitor and treat sleep apnea and snoring, today announced the conversion of the majority of debt owed to its Chairman, Boris (Bary) Molchadsky, who converted approximately $140,000 of debt into AppYea warrants with a strike price of $0.07 per share, reflecting a premium of more than 250% over the current market price of the Company's common shares.

紐約州紐約/ACCESSWIRE/2024年5月16日/用於監測和治療睡眠呼吸暫停和打鼾的創新可穿戴監測解決方案的開發商AppYea Inc.(OTCQB: APYP)今天宣佈將欠其董事長鮑里斯(Bary)Molchadsky的大部分債務轉換爲AppYea認股權證,行使價爲每股0.07美元,這反映了比公司普通股當前市場價格的溢價超過250%。

AppYea recently entered its commercial phase with the first deliveries of AppySleep to customers in the United States. Additionally, the Company has launched a new direct sales website, AppySleep.com, and a new e-commerce store on Amazon.

AppYea最近進入了商業階段,首次向美國客戶交付了AppySleep。此外,該公司還推出了一個新的直銷網站AppySleep.com,並在亞馬遜上開設了一家新的電子商務商店。

Mr. Molchadsky commented on the conversion, stating, "This conversion demonstrates my utmost confidence in the prospects and business, given the fact I am converting debt into warrants with a strike price set at a substantial premium to the current market price. The Company has made tremendous progress and I do not believe the current market price of the Company's common stock reflects the intrinsic value of our business or robust intellectual property. In particular, after years of development, we have started delivering our first product, AppySleep. There is increasing consumer awareness about the significance of healthy sleep, and our goal is to diagnose and alleviate a variety of major sleep disorders."

莫爾查德斯基對轉換髮表了評論,他說:“這次轉換表明了我對前景和業務的最大信心,因爲我正在將債務轉換爲權證,其行使價設定爲比當前市場價格高得多。公司取得了長足的進步,我認爲公司普通股的當前市場價格並不能反映我們業務的內在價值或強大的知識產權。特別是,經過多年的開發,我們已經開始交付我們的第一款產品AppySleep。消費者對健康睡眠重要性的認識不斷提高,我們的目標是診斷和緩解各種主要的睡眠障礙。”

AppYea's commitment to innovation and user-centric design marks a new era in sleep wellness. AppySleep is a compact, lightweight, and comfortable smart wristband designed for use during sleep. This wristband seamlessly incorporates multiple sensors and interfaces with the AppySleep smartphone app via Bluetooth. The app, utilizing the smartphone's microphone, actively monitors breathing patterns during sleep. When it detects several consecutive snores, the wristband responds with a gentle vibration, prompting the user to adjust their sleeping position and naturally cease snoring. The key to AppySleep's effectiveness lies in its user-friendly design and gradual training approach. Over continuous use spanning several weeks, users typically acclimate to sleeping in a correct and healthy position, significantly reducing, or eliminating snoring.

AppYea對創新和以用戶爲中心的設計的承諾標誌着睡眠健康進入了一個新時代。AppySleep 是一款小巧、輕便、舒適的智能腕帶,專爲睡眠期間使用而設計。這款腕帶通過藍牙與 AppySleep 智能手機應用程序無縫整合了多個傳感器和接口。該應用程序利用智能手機的麥克風,主動監控睡眠期間的呼吸模式。當它檢測到連續幾次打鼾時,腕帶會以輕微的振動做出響應,提示用戶調整睡眠姿勢並自然停止打鼾。AppySleep 有效的關鍵在於其用戶友好的設計和漸進式訓練方法。持續使用數週後,用戶通常會適應以正確健康的姿勢睡覺,從而顯著減少或消除打鼾。

About AppYea

關於 AppYea

AppYea is a Healthtech company commercializing innovative wearable technology for the treatment of snoring and developing wearable solutions to diagnose and treat sleep apnea. The Company's solutions are based on its proprietary IP portfolio of AI and sensing technologies for the tracking and analysis of breathing patterns, vital signs, and other physiological parameters during sleep, designed for greater accuracy at lower and affordable cost. For more information on AppYea please go to Appyea.com.

AppYea是一家健康科技公司,致力於將用於治療打鼾的創新可穿戴技術商業化,並開發可穿戴解決方案來診斷和治療睡眠呼吸暫停。該公司的解決方案基於其專有技術 知識產權組合 用於跟蹤和分析睡眠期間呼吸模式、生命體徵和其他生理參數的人工智能和傳感技術,旨在以更低和可承受的成本提高準確性。有關 AppYea 的更多信息,請訪問 Appyea.com

Cautionary Note Regarding Forward-Looking Statements

關於前瞻性陳述的警示說明

Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of AppYea are subject to many factors including, but not limited to, the sufficiency or working capital and our ability to raise the capital needed to fund our development efforts, the going concern qualification in our financials, timing of product development, customer acceptance of our products in the market, the introduction of competitive products, the effectiveness of our product distribution networks, the impact of any product liability or other adverse litigation, commercialization and technological difficulties, and the other risks identified in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission on April 1, 2024. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information, or otherwise.

本新聞稿中包含的聲明本質上不是歷史性的,是根據1995年《私人證券訴訟改革法》的安全港條款作出的前瞻性陳述。與AppYea未來業績有關的聲明受許多因素的影響,包括但不限於充足的營運資金以及我們籌集開發所需資金的能力、財務狀況的持續經營資格、產品開發的時機、客戶對我們產品在市場上的接受程度、競爭產品的推出、我們的產品分銷網絡的有效性、任何產品責任或其他不利訴訟的影響、商業化和技術困難以及公司於2024年4月1日向美國證券交易委員會提交的截至2023年12月31日止年度的10-K表年度報告中確定的其他風險。此類陳述基於管理層當前的信念和期望,存在重大風險和不確定性。實際結果可能與前瞻性陳述中列出的結果有所不同。本新聞稿中包含的前瞻性陳述是截至本新聞稿發佈之日作出的,我們沒有義務更新任何前瞻性陳述,無論是由於未來事件、新信息還是其他原因。

Contact:

聯繫人:

Crescendo Communications, LLC
Tel: (212) 671-1020
Email: APYP@Crescendo-IR.com

克雷森多通訊有限責任公司
電話:(212) 671-1020
電子郵件:APYP@Crescendo-IR.com

SOURCE: APPYEA, Inc.

資料來源:APPYEA, Inc.


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論